Some stem cell experts, including Dr. Knoepfler, are worried that the F.D.A. may loosen oversight on stem cell therapy, which could confuse the public about the difference between scientifically ...

For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...